ZIMLAB.BO
Healthcare Drug Manufacturers - Specialty & GenericZIM Laboratories Limited
₹136.25
-0.20 -0.15% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 5, 2026, live at 1:59 PM ET | 136.25 |
Key Stats
Market Cap
7.31B
Avg Volume
6,111
P/E (TTM)
166.16
EPS
₹0.82
52W High
₹145.00
52W Low
₹59.72
Div. Yield
0.0%
Valuation
P/B Ratio
2.46
P/S Ratio
1.84
EV/EBITDA
36.38
EV/Revenue
2.05
Margins
Gross Margin 53.0%
Operating Margin (3.1%)
Net Margin 0.9%
EBITDA Margin 5.6%
Growth & Returns
Revenue Growth (YoY)
31.2%
Liquidity & Leverage
Debt / Equity
0.43
Total Cash
402.52M
Total Debt
1.27B
About
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India.
www.zimlab.in